Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...

The massive rotation currently unfolding within ARK Invest suggests that Cathie Wood thinks 2026 will be the year of the ...

Beam Therapeutics Inc. (NASDAQ:BEAM) is among the 12 Best Genomics Stocks to Invest In. TheFly reported on December 2, 2025, ...

Shares of Beam Therapeutics Inc. BEAM have rallied 27.3% in the past three months compared with the industry’s increase of 9.8%. Beam’s pipeline of gene editing therapies is based on its proprietary ...

Detailed price information for Beam Therapeutics Inc (BEAM-Q) from The Globe and Mail including charting and trades.

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Beam Therapeutics Inc. (BEAM) is a stock that can certainly grab ...

Shares of Beam Therapeutics (NASDAQ: BEAM), a clinical-stage base-editing company, are under heavy pressure today. Specifically, the company's stock is down by a noteworthy 12% on higher-than-normal ...

On December 9, H.C. Wainwright analyst Patrick Trucchio reaffirmed his bullish stance on Beam Therapeutics (NASDAQ:BEAM).

Today, we are putting Beam Therapeutics back in the spotlight after an initial article on this gene editing name last summer. Beam Therapeutics' stock has sunk by a third since that avoid ...

Pre-revenue biotechs like Beam Therapeutics bring plenty of risk. The good news is that it has plenty of money and some help from Pfizer, too. But it's targeting crowded markets, and it already has a ...